Discover 658 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 658
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Milwaukee WI, Park Ridge IL, Madison WI, Chicago IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Milwaukee WI, Park Ridge IL, Madison WI, Chicago IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Location: Milwaukee WI, Park Ridge IL, Madison WI, Chicago IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase 2, Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Milwaukee WI, Madison WI, Chicago IL, Grand Rapids MI,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase 2, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Milwaukee WI, Madison WI, Chicago IL, Grand Rapids MI,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for
Childhood Extracranial Germ Cell Tumor,
Location: Milwaukee WI, Sheboygan WI, Highland Park IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT03067181
Phase 3, Recruiting
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
for
B-ALL, Hematologic Malignancy, Solid Tumor
Location: Milwaukee WI, Memphis TN, Philadelphia PA, Aurora CO,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 30
Code: NCT06579469
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Milwaukee WI, Park Ridge IL, Madison WI, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 30
Code: NCT06172296
Phase 3, Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Milwaukee WI, Park Ridge IL, Madison WI, Chicago IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Milwaukee WI, Madison WI, Chicago IL, Maywood IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase 3, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Milwaukee WI, Park Ridge IL, Madison WI, Chicago IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Milwaukee WI, Park Ridge IL, Chicago IL, Oak Lawn IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase 2, Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Location: Milwaukee WI, Canton OH, Brampton, Fairfax VA,
Sponsor: Taiho Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05967689
Phase 2, Recruiting
New
Immunotherapy and Nodal-Sparing Irradiation for T-Cell Induction and Unmasking of Tumor Antigenicity in the Microenvironment for Head and Neck Cancer
for
Head and Neck Cancer Squamous Cell Carcinoma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT07773987
Phase 2, Recruiting
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)
for
Non Small Cell Lung Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT06305715
Phase 2, Recruiting
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
for
Pancreatic Cancer
Location: Milwaukee WI, Scottsdale AZ
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04683315
Phase 2, Recruiting
Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation
for
Myeloproliferative Neoplasms
Location: Milwaukee WI, Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT06291987
Phase 1, Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
for
Neuroendocrine Tumors Unresectable,
Location: Milwaukee WI, Chicago IL, Grand Rapids MI, Iowa City IA,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05636618
Phase 1, Phase 2, Recruiting
SynCardia 70cc TAH-t for Destination Therapy (DT)
for
Life-threatening, Biventricular Heart Failure,
Location: Milwaukee WI, Richmond VA, Oklahoma City OK, Houston TX,
Sponsor: SynCardia Systems. LLC
Sex: All
Age: 19+
Code: NCT02232659
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer